Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.
Arora S, Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Bøtker HE, Rådegran G, Gude E, Ioanes D, Solbu D, Sigurdardottir V, Dellgren G, Erikstad I, Solberg OG, Ueland T, Aukrust P, Gullestad L; SCHEDULE (SCandinavian HEart transplant everolimus De novo stUdy with earLy calcineurin inhibitors avoidancE) Investigators. Arora S, et al. Among authors: eiskjaer h. Am J Transplant. 2015 Jul;15(7):1967-75. doi: 10.1111/ajt.13214. Epub 2015 Mar 17. Am J Transplant. 2015. PMID: 25783974 Free article. Clinical Trial.
Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
Gullestad L, Iversen M, Mortensen SA, Eiskjaer H, Riise GC, Mared L, Bjørtuft O, Ekmehag B, Jansson K, Simonsen S, Gude E, Rundqvist B, Fagertun HE, Solbu D, Bergh CH. Gullestad L, et al. Among authors: eiskjaer h. Transplantation. 2010 Apr 15;89(7):864-72. doi: 10.1097/TP.0b013e3181cbac2d. Transplantation. 2010. PMID: 20061999 Clinical Trial.
Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function.
Halbirk M, Nørrelund H, Møller N, Schmitz O, Gøtzsche L, Nielsen R, Nielsen-Kudsk JE, Nielsen SS, Nielsen TT, Eiskjær H, Bøtker HE, Wiggers H. Halbirk M, et al. Among authors: eiskjaer h. Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1220-5. doi: 10.1152/ajpheart.00475.2010. Epub 2010 Aug 13. Am J Physiol Heart Circ Physiol. 2010. PMID: 20709866 Free article. Clinical Trial.
Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial.
Gullestad L, Mortensen SA, Eiskjær H, Riise GC, Mared L, Bjørtuft O, Ekmehag B, Jansson K, Simonsen S, Gude E, Rundqvist B, Fagertun HE, Solbu D, Iversen M. Gullestad L, et al. Among authors: eiskjaer h. Transplantation. 2010 Dec 27;90(12):1581-9. doi: 10.1097/TP.0b013e3181fd01b7. Transplantation. 2010. PMID: 21030905 Clinical Trial.
Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial.
Arora S, Ueland T, Wennerblom B, Sigurdadottir V, Eiskjær H, Bøtker HE, Ekmehag B, Jansson K, Mortensen SA, Saunamaki K, Simonsen S, Gude E, Bendz B, Solbu D, Aukrust P, Gullestad L. Arora S, et al. Among authors: eiskjaer h. Transplantation. 2011 Jul 27;92(2):235-43. doi: 10.1097/TP.0b013e31822057f1. Transplantation. 2011. PMID: 21677600 Clinical Trial.
Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate.
Arora S, Gude E, Sigurdardottir V, Mortensen SA, Eiskjær H, Riise G, Mared L, Bjørtuft O, Ekmehag B, Jansson K, Simonsen S, Aukrust P, Solbu D, Iversen M, Gullestad L. Arora S, et al. Among authors: eiskjaer h. J Heart Lung Transplant. 2012 Mar;31(3):259-65. doi: 10.1016/j.healun.2011.12.010. J Heart Lung Transplant. 2012. PMID: 22333403 Clinical Trial.
Virtual histology assessment of cardiac allograft vasculopathy following introduction of everolimus--results of a multicenter trial.
Arora S, Erikstad I, Ueland T, Sigurdardottir V, Ekmehag B, Jansson K, Eiskjaer H, Bøtker HE, Mortensen SA, Saunamaki K, Gude E, Ragnarsson A, Solbu D, Aukrust P, Gullestad L. Arora S, et al. Among authors: eiskjaer h. Am J Transplant. 2012 Oct;12(10):2700-9. doi: 10.1111/j.1600-6143.2012.04234.x. Epub 2012 Sep 7. Am J Transplant. 2012. PMID: 22958738 Free article. Clinical Trial.
Three decades of heart transplantation in Scandinavia: long-term follow-up.
Dellgren G, Geiran O, Lemström K, Gustafsson F, Eiskjaer H, Koul B, Hagerman I, Selimovic N; Nordic Thoracic Transplant Study Group. Dellgren G, et al. Among authors: eiskjaer h. Eur J Heart Fail. 2013 Mar;15(3):308-15. doi: 10.1093/eurjhf/hfs160. Epub 2012 Oct 29. Eur J Heart Fail. 2013. PMID: 23109651 Free article.
194 results